{"id":86467,"date":"2026-05-13T14:08:43","date_gmt":"2026-05-13T08:38:43","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=86467"},"modified":"2026-05-13T14:08:45","modified_gmt":"2026-05-13T08:38:45","slug":"sakar-healthcare-q4-fy26-results-pat-rs-11-02-crore-up-91-percent-revenue-rs-71-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/sakar-healthcare-q4-fy26-results-pat-rs-11-02-crore-up-91-percent-revenue-rs-71-crore\/","title":{"rendered":"Sakar Healthcare Q4 FY26 Results: PAT Rs 11.02 Crore Up 91.32 Percent YoY Revenue Rs 71.10 Crore Operating Margin 36.91 Percent"},"content":{"rendered":"<div class=\"meta-block\">\u00a0<\/div>\n<p><a href=\"https:\/\/univest.in\/user\/stocks\/sakar\/sakar-healthcare-ltd-share-price-today\">Sakar Healthcare<\/a> Q4 FY26 results were announced on 12 May 2026, with the Ahmedabad-based specialty pharmaceutical company reporting a consolidated net profit of Rs 11.02 crore for the quarter ended March 31, 2026, a robust 91.32 percent year-on-year surge from the year-ago period. <strong>Sakar Healthcare Q4 FY26<\/strong> revenue climbed to Rs 71.10 crore, a 41.52 percent year-on-year expansion, with a modest 1.08 percent sequential gain. Most impressively, the company achieved its highest-ever quarterly operating margin (excluding other income) of 36.91 percent in Q4 FY26, a 560 basis point expansion from the previous quarter and an equivalent improvement year-on-year. The stock responded positively, gaining 4.94 percent to close at Rs 597.80 on 13 May 2026.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\">Click Here \u2013 Get Free Investment Predictions<\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/sakar-healthcare-q4-fy26-results-pat-rs-11-02-crore-up-91-percent-revenue-rs-71-crore\/#Sakar_Healthcare_Q4_FY26_Key_Financial_Highlights\" title=\"Sakar Healthcare Q4 FY26 Key Financial Highlights\">Sakar Healthcare Q4 FY26 Key Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/sakar-healthcare-q4-fy26-results-pat-rs-11-02-crore-up-91-percent-revenue-rs-71-crore\/#Sakar_Healthcare_Q4_FY26_Stellar_Performance_Analysis\" title=\"Sakar Healthcare Q4 FY26 Stellar Performance Analysis\">Sakar Healthcare Q4 FY26 Stellar Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/sakar-healthcare-q4-fy26-results-pat-rs-11-02-crore-up-91-percent-revenue-rs-71-crore\/#Frequently_Asked_Questions_on_Sakar_Healthcare_Q4_FY26_Results\" title=\"Frequently Asked Questions on Sakar Healthcare Q4 FY26 Results\">Frequently Asked Questions on Sakar Healthcare Q4 FY26 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/sakar-healthcare-q4-fy26-results-pat-rs-11-02-crore-up-91-percent-revenue-rs-71-crore\/#What_is_Sakar_Healthcare_Q4_FY26_net_profit\" title=\"What is Sakar Healthcare Q4 FY26 net profit?\">What is Sakar Healthcare Q4 FY26 net profit?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/sakar-healthcare-q4-fy26-results-pat-rs-11-02-crore-up-91-percent-revenue-rs-71-crore\/#What_was_Sakar_Healthcare_Q4_FY26_operating_margin\" title=\"What was Sakar Healthcare Q4 FY26 operating margin?\">What was Sakar Healthcare Q4 FY26 operating margin?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/sakar-healthcare-q4-fy26-results-pat-rs-11-02-crore-up-91-percent-revenue-rs-71-crore\/#How_did_the_market_react_to_Sakar_Healthcare_Q4_FY26\" title=\"How did the market react to Sakar Healthcare Q4 FY26?\">How did the market react to Sakar Healthcare Q4 FY26?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/sakar-healthcare-q4-fy26-results-pat-rs-11-02-crore-up-91-percent-revenue-rs-71-crore\/#Where_can_I_track_Sakar_Healthcare_live_price\" title=\"Where can I track Sakar Healthcare live price?\">Where can I track Sakar Healthcare live price?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Sakar_Healthcare_Q4_FY26_Key_Financial_Highlights\"><\/span><strong>Sakar Healthcare Q4 FY26 Key Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th><strong>Parameter<\/strong><\/th>\n<th><strong>Q4 FY26<\/strong><\/th>\n<th><strong>Reference<\/strong><\/th>\n<\/tr>\n<tr>\n<td><strong>Net Profit (PAT)<\/strong><\/td>\n<td>Rs 11.02 crore<\/td>\n<td>+91.32% YoY<\/td>\n<\/tr>\n<tr>\n<td><strong>Revenue from Operations<\/strong><\/td>\n<td>Rs 71.10 crore<\/td>\n<td>+41.52% YoY<\/td>\n<\/tr>\n<tr>\n<td><strong>Operating Margin<\/strong><\/td>\n<td>36.91%<\/td>\n<td>Highest ever; +560 bps QoQ<\/td>\n<\/tr>\n<tr>\n<td><strong>PAT Margin<\/strong><\/td>\n<td>15.50%<\/td>\n<td>+4.04 percentage points YoY<\/td>\n<\/tr>\n<tr>\n<td><strong>Stock Reaction<\/strong><\/td>\n<td>+4.94% on May 13<\/td>\n<td>Closed at Rs 597.80<\/td>\n<\/tr>\n<tr>\n<td><strong>Market Cap<\/strong><\/td>\n<td>Approx. Rs 1,330 crore<\/td>\n<td>Micro-cap pharma<\/td>\n<\/tr>\n<tr>\n<td><strong>NSE Ticker<\/strong><\/td>\n<td>SAKARBIO<\/td>\n<td>Sector: Specialty Pharmaceuticals<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><a href=\"https:\/\/univest.in\/screeners\">Screen the best stocks on the Univest Screener.<\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sakar_Healthcare_Q4_FY26_Stellar_Performance_Analysis\"><\/span><strong>Sakar Healthcare Q4 FY26 Stellar Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Sakar Healthcare Q4 FY26<\/strong> results represent a standout quarterly performance, with revenue growth of 41.52 percent, PAT growth of 91.32 percent, and the highest-ever operating margin of 36.91 percent. The operating margin expansion of 560 basis points from the previous quarter and from the year-ago period reflects Sakar Healthcare&#8217;s successful scaling of its specialty pharmaceutical products with improving pricing power and operating leverage. The PAT margin improvement to 15.50 percent from 11.46 percent year-on-year demonstrates that revenue growth is efficiently converting to bottom-line gains. Sakar Healthcare&#8217;s products span pharmaceutical formulations, nutraceuticals, and specialty health products.<\/p>\n<p>The stock&#8217;s strong 93.53 percent one-year return has pushed it to a price-to-earnings ratio of approximately 41x, which investors should note when assessing entry points. Post <strong>Sakar Healthcare Q4 FY26 results<\/strong>, the sustainability of the 36.91 percent operating margin will be the key question, alongside management commentary on new product launches, regulatory approvals, and the revenue growth trajectory in FY27.<\/p>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to get daily stock recommendations and expert research.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Sakar_Healthcare_Q4_FY26_Results\"><\/span><strong>Frequently Asked Questions on Sakar Healthcare Q4 FY26 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Sakar_Healthcare_Q4_FY26_net_profit\"><\/span><strong>What is Sakar Healthcare Q4 FY26 net profit?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sakar Healthcare Q4 FY26 consolidated net profit is Rs 11.02 crore, a 91.32 percent year-on-year surge, with revenue up 41.52 percent to Rs 71.10 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_Sakar_Healthcare_Q4_FY26_operating_margin\"><\/span><strong>What was Sakar Healthcare Q4 FY26 operating margin?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sakar Healthcare Q4 FY26 operating margin (excluding other income) was 36.91 percent, the highest in the company&#8217;s recent history, representing a 560 basis point expansion from the previous quarter.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_the_market_react_to_Sakar_Healthcare_Q4_FY26\"><\/span><strong>How did the market react to Sakar Healthcare Q4 FY26?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sakar Healthcare stock gained 4.94 percent to close at Rs 597.80 on May 13, 2026, reflecting positive investor response to the strong Q4 FY26 results and highest-ever operating margin.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_Sakar_Healthcare_live_price\"><\/span><strong>Where can I track Sakar Healthcare live price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Track Sakar Healthcare live price, analyst ratings, and Q4 FY26 earnings updates on the Univest Screener.<\/p>\n<p><em>Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. All financial data cited is sourced from BSE\/NSE exchange filings and verified news sources. Investments in securities are subject to market risk. Consult a SEBI-registered investment advisor before making any investment decision.<\/em><\/p><p><\/p>","protected":false},"excerpt":{"rendered":"<p>Sakar Healthcare Q4 FY26: PAT Rs 11.02 crore (+91.32%), revenue Rs 71.10 crore (+41.52%), operating margin 36.91% (highest ever). Stock gained 4.94% post results.<\/p>\n","protected":false},"author":34,"featured_media":86648,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,4027],"class_list":["post-86467","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-q4-fy26-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1778665680:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["71"],"rank_math_title":["Sakar Healthcare Q4 FY26 Results: PAT Rs 11.02 Crore Up 91 Percent Revenue Rs 71 Crore"],"rank_math_description":["Sakar Healthcare Q4 FY26 results: PAT Rs 11.02 crore, up 91.32% YoY. Revenue Rs 71.10 crore, up 41.52%. Operating margin 36.91%, highest ever. Gujarat pharma. Full analysis."],"rank_math_focus_keyword":["Sakar Healthcare Q4 FY26 results"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_thumbnail_id":["86648"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["11226"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/05\/13140623\/Sakar-Healthcare-Q4-FY26-results.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/86467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=86467"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/86467\/revisions"}],"predecessor-version":[{"id":86652,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/86467\/revisions\/86652"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/86648"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=86467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=86467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=86467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}